Search

everythinglearnresearchcommunity

for

Search:↓

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Eating high-glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.